Picture of Alliance Pharma logo

APH — Alliance Pharma News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Asset management firm DBAY to buy UK's Alliance Pharma in $430 mln deal

Jan 10 (Reuters) - Britain's Alliance Pharma  ALAPH.L 
said on Friday it has agreed to be acquired by asset management
firm DBAY Advisors in an all-cash deal valuing the healthcare
group at 349.7 million pounds ($429.6 million).
 
 ($1 = 0.8140 pounds)

 (Reporting by Aby Jose Koilparambil in Bengaluru; Editing by
Savio D'Souza)
 ((abyjose.koilparambil@thomsonreuters.com))

Recent news on Alliance Pharma

See all news